Company / Gross Margin
West Pharmaceutical Services Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
35.9%
FY2025
5-year range
32.9% / 38.3%
FY2021-FY2025
Trend
+4.1%
vs FY2024
Sector context
#76 of 96
Health Care
What the data says
West Pharmaceutical Services's gross margin of 35.9% is lower than 79% of companies in the Health Care sector (FY2025). Gross Margin has fluctuated over the past 10 years, ranging from 31.5% in FY2016 to 38.3% in FY2023.
Based on SEC 10-K filings.
35.9% in FY2025 with a 5-year CAGR of +4.1%.
Declined from 38.3% to 35.9% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +0.2pp
- 5-Year Change
- +4.1pp
- 10-Year Change
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 96This company 35.9% Sector average 53.6%
▼
-33.0% below sector average
Key checks
Key Insights
- In FY2025, gross margin increased 4.1% year-over-year.
- Currently 17.7pp below the Health Care sector average.
- Peak gross margin was recorded in FY2023.
- Lowest gross margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 35.9% | +4.1% |
| FY2024 | 34.5% | -9.8% |
| FY2023 | 38.3% | +7.0% |
| FY2022 | 35.8% | +8.6% |
| FY2021 | 32.9% | +3.7% |
| FY2020 | 31.8% | -3.5% |
| FY2019 | 32.9% | +3.7% |
| FY2018 | 31.8% | -1.0% |
| FY2017 | 32.1% | +1.8% |
| FY2016 | 31.5% | -0.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026